Increased vascular endothelial growth factor expression in human hearts with microvascular fibrin

Ronald J. Torry, Ling Bai, Steven Miller, Carlos A. Labarrere, David Nelson, Donald S. Torry

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

We have shown that microvascular changes that promote fibrin deposition in human cardiac allografts adversely affect clinical outcome. However, some allografts exhibit phenotypic changes in capillaries following the deposition of fibrin, which subsequently provide a significant survival advantage. The mechanism(s) involved in these capillary changes is(are) unknown. Similarly, although we have shown a significant temporal relationship between microvascular fibrin deposition and vascular endothelial growth factor (VEGF) immunoreactivity in cardiac allografts, the cellular source and relative changes in VEGF gene expression under these conditions are not known. Using immunocytochemical techniques, biopsies devoid of fibrin deposition lacked detectable VEGF immunoreactivity, whereas biopsies with fibrin deposition showed VEGF immunoreactivity in cardiocytes, interstitium, and some microvessels. By in situ hybridization, biopsies without microvascular fibrin deposition showed faint VEGF hybridization signals confined primarily to cardiocytes. In biopsies with fibrin deposition, strong VEGF hybridization signals were detected in cardiocytes, arteriolar smooth muscle cells were occasionally labeled, and endothelial cells were rarely labeled. By quantitative RT-PCR, biopsies with fibrin deposition (n=5) relatively expressed ∼three-fold more VEGF mRNA than biopsies without fibrin deposition (n=5; P=0.02). Serum VEGF titers also were greater (P=0.01) in recipients with fibrin deposition (372.9±66.7 pg/ml; n=18) compared to recipients without fibrin deposition (172.1±25.0 pg/ml; n=16). Collectively, these results support the hypothesis that increased myocyte-derived VEGF production following microvascular fibrin deposition in transplanted human hearts may act in a paracrine manner to promote activational and phenotypic changes in capillaries that provide a survival advantage for the allografts.

Original languageEnglish
Pages (from-to)175-184
Number of pages10
JournalJournal of Molecular and Cellular Cardiology
Volume33
Issue number1
DOIs
StatePublished - 2001

Fingerprint

Fibrin
Vascular Endothelial Growth Factor A
Biopsy
Allografts
Survival
Microvessels
Muscle Cells
Smooth Muscle Myocytes
In Situ Hybridization
Endothelial Cells
Gene Expression
Polymerase Chain Reaction
Messenger RNA

Keywords

  • Angiogenesis
  • Capillaries
  • Gene expression
  • Growth factors
  • Human

ASJC Scopus subject areas

  • Molecular Biology
  • Cardiology and Cardiovascular Medicine

Cite this

Increased vascular endothelial growth factor expression in human hearts with microvascular fibrin. / Torry, Ronald J.; Bai, Ling; Miller, Steven; Labarrere, Carlos A.; Nelson, David; Torry, Donald S.

In: Journal of Molecular and Cellular Cardiology, Vol. 33, No. 1, 2001, p. 175-184.

Research output: Contribution to journalArticle

Torry, Ronald J. ; Bai, Ling ; Miller, Steven ; Labarrere, Carlos A. ; Nelson, David ; Torry, Donald S. / Increased vascular endothelial growth factor expression in human hearts with microvascular fibrin. In: Journal of Molecular and Cellular Cardiology. 2001 ; Vol. 33, No. 1. pp. 175-184.
@article{dec7fc4dd3b2424783eccda1937e973f,
title = "Increased vascular endothelial growth factor expression in human hearts with microvascular fibrin",
abstract = "We have shown that microvascular changes that promote fibrin deposition in human cardiac allografts adversely affect clinical outcome. However, some allografts exhibit phenotypic changes in capillaries following the deposition of fibrin, which subsequently provide a significant survival advantage. The mechanism(s) involved in these capillary changes is(are) unknown. Similarly, although we have shown a significant temporal relationship between microvascular fibrin deposition and vascular endothelial growth factor (VEGF) immunoreactivity in cardiac allografts, the cellular source and relative changes in VEGF gene expression under these conditions are not known. Using immunocytochemical techniques, biopsies devoid of fibrin deposition lacked detectable VEGF immunoreactivity, whereas biopsies with fibrin deposition showed VEGF immunoreactivity in cardiocytes, interstitium, and some microvessels. By in situ hybridization, biopsies without microvascular fibrin deposition showed faint VEGF hybridization signals confined primarily to cardiocytes. In biopsies with fibrin deposition, strong VEGF hybridization signals were detected in cardiocytes, arteriolar smooth muscle cells were occasionally labeled, and endothelial cells were rarely labeled. By quantitative RT-PCR, biopsies with fibrin deposition (n=5) relatively expressed ∼three-fold more VEGF mRNA than biopsies without fibrin deposition (n=5; P=0.02). Serum VEGF titers also were greater (P=0.01) in recipients with fibrin deposition (372.9±66.7 pg/ml; n=18) compared to recipients without fibrin deposition (172.1±25.0 pg/ml; n=16). Collectively, these results support the hypothesis that increased myocyte-derived VEGF production following microvascular fibrin deposition in transplanted human hearts may act in a paracrine manner to promote activational and phenotypic changes in capillaries that provide a survival advantage for the allografts.",
keywords = "Angiogenesis, Capillaries, Gene expression, Growth factors, Human",
author = "Torry, {Ronald J.} and Ling Bai and Steven Miller and Labarrere, {Carlos A.} and David Nelson and Torry, {Donald S.}",
year = "2001",
doi = "10.1006/jmcc.2000.1292",
language = "English",
volume = "33",
pages = "175--184",
journal = "Journal of Molecular and Cellular Cardiology",
issn = "0022-2828",
publisher = "Academic Press Inc.",
number = "1",

}

TY - JOUR

T1 - Increased vascular endothelial growth factor expression in human hearts with microvascular fibrin

AU - Torry, Ronald J.

AU - Bai, Ling

AU - Miller, Steven

AU - Labarrere, Carlos A.

AU - Nelson, David

AU - Torry, Donald S.

PY - 2001

Y1 - 2001

N2 - We have shown that microvascular changes that promote fibrin deposition in human cardiac allografts adversely affect clinical outcome. However, some allografts exhibit phenotypic changes in capillaries following the deposition of fibrin, which subsequently provide a significant survival advantage. The mechanism(s) involved in these capillary changes is(are) unknown. Similarly, although we have shown a significant temporal relationship between microvascular fibrin deposition and vascular endothelial growth factor (VEGF) immunoreactivity in cardiac allografts, the cellular source and relative changes in VEGF gene expression under these conditions are not known. Using immunocytochemical techniques, biopsies devoid of fibrin deposition lacked detectable VEGF immunoreactivity, whereas biopsies with fibrin deposition showed VEGF immunoreactivity in cardiocytes, interstitium, and some microvessels. By in situ hybridization, biopsies without microvascular fibrin deposition showed faint VEGF hybridization signals confined primarily to cardiocytes. In biopsies with fibrin deposition, strong VEGF hybridization signals were detected in cardiocytes, arteriolar smooth muscle cells were occasionally labeled, and endothelial cells were rarely labeled. By quantitative RT-PCR, biopsies with fibrin deposition (n=5) relatively expressed ∼three-fold more VEGF mRNA than biopsies without fibrin deposition (n=5; P=0.02). Serum VEGF titers also were greater (P=0.01) in recipients with fibrin deposition (372.9±66.7 pg/ml; n=18) compared to recipients without fibrin deposition (172.1±25.0 pg/ml; n=16). Collectively, these results support the hypothesis that increased myocyte-derived VEGF production following microvascular fibrin deposition in transplanted human hearts may act in a paracrine manner to promote activational and phenotypic changes in capillaries that provide a survival advantage for the allografts.

AB - We have shown that microvascular changes that promote fibrin deposition in human cardiac allografts adversely affect clinical outcome. However, some allografts exhibit phenotypic changes in capillaries following the deposition of fibrin, which subsequently provide a significant survival advantage. The mechanism(s) involved in these capillary changes is(are) unknown. Similarly, although we have shown a significant temporal relationship between microvascular fibrin deposition and vascular endothelial growth factor (VEGF) immunoreactivity in cardiac allografts, the cellular source and relative changes in VEGF gene expression under these conditions are not known. Using immunocytochemical techniques, biopsies devoid of fibrin deposition lacked detectable VEGF immunoreactivity, whereas biopsies with fibrin deposition showed VEGF immunoreactivity in cardiocytes, interstitium, and some microvessels. By in situ hybridization, biopsies without microvascular fibrin deposition showed faint VEGF hybridization signals confined primarily to cardiocytes. In biopsies with fibrin deposition, strong VEGF hybridization signals were detected in cardiocytes, arteriolar smooth muscle cells were occasionally labeled, and endothelial cells were rarely labeled. By quantitative RT-PCR, biopsies with fibrin deposition (n=5) relatively expressed ∼three-fold more VEGF mRNA than biopsies without fibrin deposition (n=5; P=0.02). Serum VEGF titers also were greater (P=0.01) in recipients with fibrin deposition (372.9±66.7 pg/ml; n=18) compared to recipients without fibrin deposition (172.1±25.0 pg/ml; n=16). Collectively, these results support the hypothesis that increased myocyte-derived VEGF production following microvascular fibrin deposition in transplanted human hearts may act in a paracrine manner to promote activational and phenotypic changes in capillaries that provide a survival advantage for the allografts.

KW - Angiogenesis

KW - Capillaries

KW - Gene expression

KW - Growth factors

KW - Human

UR - http://www.scopus.com/inward/record.url?scp=0035142595&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035142595&partnerID=8YFLogxK

U2 - 10.1006/jmcc.2000.1292

DO - 10.1006/jmcc.2000.1292

M3 - Article

C2 - 11133233

AN - SCOPUS:0035142595

VL - 33

SP - 175

EP - 184

JO - Journal of Molecular and Cellular Cardiology

JF - Journal of Molecular and Cellular Cardiology

SN - 0022-2828

IS - 1

ER -